FDA Issues Summary of Recent Workshop on Assessment of Written Patient Medicine Information Leaflets

A summary and transcripts of FDA’s Feb. 29-March 1 workshop on a Univ. of Wisconsin assessment of written patient leaflets distributed in 300 community pharmacies is available on FDA’s website. This assessment is the first and most comprehensive evaluation of written information against the criteria developed by NCPIE and other stakeholders in the Action Plan for the Provision of Useful Prescription Drug Information.